Pricing Log in Create free account

Nanobiotix S.A. - Sponsored ADR (NBTX) vs Rapport Therapeutics, Inc. (RAPP)

Nanobiotix S.A. - Sponsored ADR and Rapport Therapeutics, Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and Rapport Therapeutics, Inc. are of similar size ($1.7B and $1.5B). Across the 7 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 4 and Rapport Therapeutics, Inc. on 3.

Valuation

Metric NBTX RAPP Biotechnology median
P/E n/m n/m 10.96
P/S 6,515.40 n/m 9.52
P/B n/m 3.17 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 5,759.89 n/m 9.00
Earnings yield (10.18%) (12.22%) (32.09%)
Free cash flow yield (12.83%) (9.74%) (22.62%)

Profitability

Metric NBTX RAPP Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (33.33%) (50.12%)
Return on assets 0.00% (31.55%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NBTX RAPP Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 63.46% 24.34% 29.88%
Revenue growth, 5-year CAGR 66.64% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NBTX RAPP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.44 20.07 4.74
Net debt to EBITDA 5.66 3.91 1.01

Dividend

Metric NBTX RAPP Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric NBTX RAPP Biotechnology median
Market cap 1.67b 1.54b 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack